The business conducted clinical trials of new potential drug treatments on behalf of sponsor companies seeking approval from ...

Bay Area drug giant Gilead is plotting the trial of a groundbreaking, once-a-year HIV prevention drug lenacapavir.

For participants in clinical trials, the answer is a hard no. The Trump administration's decision to end funding for the U.S.

While China has become a key country for global clinical trials, navigating regulatory complexities and ensuring data ...

Leading pharmaceutical companies, including Dr Reddy's, Sun Pharma, Cipla, Mankind Pharma, and Natco Pharma, among others, ...

Another company involved in using AI to repurpose failed drugs – as well as drugs that have already been approved – is ...

Tv Therapeutics said that the U.S. FDA has lifted the clinical hold on the cadisegliatin clinical program, including late ...

An indigenously developed gene therapy for specific blood cancers has shown a 73 per cent response rate among patients in ...

Cadisegliatin has the potential to be the first oral adjunct therapy for type 1 diabetesCATT1 Phase 3 trial expected to resume following ...

Cadisegliatin, which was paused in the third phase of its CATT1 trial, is taken orally and is designed to target the liver specifically and aims to treat diabetes by improving blood sugar control. VTv ...

The owners of a Pembroke Pines-based medical research facility pleaded guilty Monday to charges they faked information around ...

The study looked at patients with leukaemia, which occurs in bone marrow, and lymphoma, which affects the lymphatic system.